|
SRRD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62470037423645E-12 |
| Normal-vs-Stage2 |
1.61320000002796E-06 |
| Normal-vs-Stage3 |
1.570280E-02 |
| Normal-vs-Stage4 |
6.40889996628147E-09 |
| Stage1-vs-Stage2 |
9.352000E-01 |
| Stage1-vs-Stage3 |
1.142390E-01 |
| Stage1-vs-Stage4 |
6.274200E-01 |
| Stage2-vs-Stage3 |
1.815990E-01 |
| Stage2-vs-Stage4 |
5.437000E-01 |
| Stage3-vs-Stage4 |
8.047600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-16 |
| Normal-vs-AfricanAmerican |
1.72317715652071E-12 |
| Normal-vs-Asian |
2.293900E-02 |
| Caucasian-vs-AfricanAmerican |
4.638600E-01 |
| Caucasian-vs-Asian |
6.358000E-01 |
| AfricanAmerican-vs-Asian |
7.413200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
5.41250000041238E-07 |
| Male-vs-Female |
3.697200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.46389591957086E-11 |
| Normal-vs-Extreme_Weight |
5.88418203051333E-15 |
| Normal-vs-Obese |
1.68060000005354E-06 |
| Normal-vs-Extreme_Obese |
1.323700E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.496200E-01 |
| Normal_Weight-vs-Obese |
9.249900E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.046000E-01 |
| Extreme_Weight-vs-Obese |
6.532300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.811200E-01 |
| Obese-vs-Extreme_Obese |
2.394000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.184930E-03 |
| Normal-vs-Age(41-60Yrs) |
1.89269711015072E-11 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
5.08482145278322E-13 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.697600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.199200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.226210E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.649760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.936130E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.852300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.59920000020186E-07 |
| Normal-VS-KIRP CIMP |
2.423800E-02 |
| Normal-VS-Unclassified PRCC |
1.28779999997164E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.035800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.591000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.801000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.616000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.326800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.712200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.8693999953866E-08 |
| Normal-vs-N1 |
4.844800E-03 |
| Normal-vs-N2 |
1.277390E-01 |
| N0-vs-N1 |
3.434600E-01 |
| N0-vs-N2 |
8.667400E-01 |
| N1-vs-N2 |
5.748200E-01 |
|
|
